Navigation Links
BD Board of Directors Elects John R. Considine as Vice Chairman and Member of the Board of Directors
Date:3/18/2008

FRANKLIN LAKES, N.J., March 18 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it has elected John R. Considine as Vice Chairman and Chief Financial Officer of BD and a member of the Board of Directors, effective immediately. Mr. Considine is currently Senior Executive Vice President and Chief Financial Officer of BD. With his election, the BD Board consists of 14 members, all of whom are independent with the exception of Mr. Considine and Edward J. Ludwig, Chairman, President and Chief Executive Officer.

Mr. Considine, 57, joined BD in May 2000 as Executive Vice President and Chief Financial Officer, after spending 17 years at Wyeth in various financial roles including Senior Vice President - Finance of the corporation. He is currently responsible for worldwide finance, information technology, manufacturing, quality and supply chain operations. Mr. Considine will stand for election at BD's Annual Meeting of Shareholders in 2009. He is expected to serve on the Board of Directors until his planned retirement from BD following the 2010 Annual Meeting.

"I look forward to working closely with John over the next two years to further our strategy of increasing revenue growth through innovation, complemented by driving operating effectiveness and productivity," said Edward J. Ludwig, Chairman, President and Chief Executive Officer. "John has proven his value to the Company, at both the strategic and operational levels, and he will bring unique skills and depth of knowledge to the Board. His contributions will be instrumental in paving the path for BD's continued success, and I look forward to working with him in his expanded role."

About BD

BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people's health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. For more information, please visit http://www.bd.com.


'/>"/>
SOURCE BD (Becton, Dickinson and Company)
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hillenbrand Industries Announces Formal Board Approval of Separation by Means of Share Distribution and Details for Completion
2. Conseco Declines Partnerships Request for Board Seats; Review of Strategic Alternatives Underway
3. Weight Watchers Announces Election of Kim Roy to Board of Directors
4. Previously Disclosed Changes in Board Composition of NightHawk Radiology Holdings, Inc. Prompt Notice of Noncompliance from the Nasdaq Global Market
5. CardioDynamics Board of Directors Proposes Reverse Split 1:7 of Companys Shares
6. Alexander M. Cutler Nominated for Election to DuPont Board of Directors
7. Stuart Altman, Ph.D. Joins INSPIRIS Board of Directors
8. Hospital Caregivers Unveil Billboards Calling for Improved Patient Care, Quality Jobs at Community Medical Centers
9. First-Ever National Board Certification(R) for Americas Health Educators Arrives
10. Ventas Appoints James D. Shelton and Robert D. Reed to Board
11. Former Federal Reserve Chairman Paul Volcker To Join Board of Directors of Still River Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) ... measures required to build a strong and stable market ... listed on the OTC Markets-pink current trading platform. ... "We are seeing an anomaly in market trading activities ... by the Company, but shareholders and market players as ...
(Date:6/24/2016)... Calif. , June 24, 2016  Global ... a biopharmaceutical company developing novel therapeutics for the ... needs, today announced the closing of its previously ... common stock, at the public offering price of ... the offering were offered by GBT. GBT estimates ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
Breaking Medicine Technology: